Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Intra-Cellular Therapies Inc. (ITCI)

  • Company Report
  • Aug. 09, 2022, 05:10 UTC
  • 37

New Form 10-Q for Intra-Cellular Therapies Inc.

Comment Full text

Epizyme Inc. (EPZM)

  • Company Report
  • Aug. 09, 2022, 04:28 UTC
  • 30

New Form 10-Q for Epizyme, Inc.

Comment Full text

Novavax Inc (NVAX)

  • Company Report
  • Aug. 09, 2022, 03:38 UTC
  • 31

New SEC Filing for Novavax Inc. (NASDAQ:NVAX)

Comment Full text

Tonix Pharmaceuticals Holding Corp. (TNXP)

  • Company Report
  • Aug. 08, 2022, 14:11 UTC
  • 32

New SEC Form for Tonix Pharmaceuticals Holding Corp.

Comment Full text

ChemoCentryx Inc. (CCXI)

  • Company Report
  • Aug. 08, 2022, 14:09 UTC
  • 30

New Form 10-Q for ChemoCentryx, Inc.

Comment Full text

Sutro Biopharma Inc. (STRO)

  • Company Report
  • Aug. 08, 2022, 13:45 UTC
  • 31

New SEC Form for Sutro Biopharma, Inc.

Comment Full text

Cara Therapeutics (CARA)

  • Company Report
  • Aug. 08, 2022, 13:43 UTC
  • 31

New Form 10-Q for Cara Therapeutics

Comment Full text

Syndax Pharmaceuticals Inc. (SNDX)

  • Company Report
  • Aug. 08, 2022, 13:15 UTC
  • 29

New Form 10-Q for Syndax Pharmaceuticals, Inc.

Comment Full text

MacroGenics Inc. (MGNX)

  • Company Report
  • Aug. 08, 2022, 13:13 UTC
  • 31

New Form 10-Q for MacroGenics, Inc.

Comment Full text

Prothena Corporation plc (PRTA)

  • Company Report
  • Aug. 08, 2022, 13:12 UTC
  • 31

Prothena Corporation plc - Second Quarter 2022

Comment Full text
  • Previous
  • 64
  • 65
  • 66
  • 67
  • 68
  • Next

Search

News categories

  • Technical Exchange News(9351)
  • Event(407)
  • SEC News(152535)
  • FDA Approval(8712)
  • Company Report(721)
  • Business News(104235)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin